Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2022 07:00 ET | Source: Acumen Research and Consulting

Animal Health Market Size to Garner a Revenue of USD 67,330 Million By 2030 At CAGR of 5.8% - Exclusive Report By Acumen Research And Consulting

NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The global animal health market size is expected to reach the market value of USD 67,330 million by 2030, growing at a CAGR of 5.8% during the forecast...
August 03, 2022 07:00 ET | Source: Nurix Therapeutics, Inc.

Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer

SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs, today announced...
August 03, 2022 05:31 ET | Source: Visiongain Reports Ltd

Global Synthetic Biology Market Is Projected to Grow at a CAGR of 25.52% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Synthetic Biology 2022-2032. It includes profiles of Synthetic Biology and Forecasts Market Segment by Product Type (Application Product Type, Technology...
August 03, 2022 03:01 ET | Source: Mainz BioMed NV

Mainz Biomed Appoints Former QIAGEN Executive Dr. Frank Krieg-Schneider as Vice President of Development

BERKELEY, Calif. and MAINZ, Germany, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
August 03, 2022 03:00 ET | Source: Gordon Brothers

Gordon Brothers Acquires ORSAY Brand & Partners with SCAYLE for Continued Growth

Cologne, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Gordon Brothers, the global advisory, restructuring and investment firm, has acquired the global ORSAY brand, archives, and related trademarks and other...
August 02, 2022 16:15 ET | Source: Generation Bio Co.

Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
August 02, 2022 16:05 ET | Source: Codexis, Inc.

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

REDWOOD CITY, Calif. and SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular...
August 02, 2022 16:05 ET | Source: Codex DNA, Inc.

Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022

SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2022...
August 02, 2022 09:56 ET | Source: Allied Market Research

Women’s Health App Market to Reach $18.25 Billion by 2031, Allied Market Research Says

Portland, OR, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global women’s health app market generated $2.88 billion in 2021, and is estimated to...
August 02, 2022 08:30 ET | Source: Beam Therapeutics

Beam Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that...